TG THERAPEUTICS, INC. business relationships
Companies named in TG THERAPEUTICS, INC.’s 10-K filed 2026-02-27, and public companies whose annual reports name TG THERAPEUTICS, INC.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.4 / 10
- AI naming
- 71 / 100 Top 1% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in TG THERAPEUTICS, INC.’s annual report 2
“License Agreement by and between TG Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated, dated June 23, 2014 (incorporated by reference to Exhibit 10.1 to the Registrant's Form 10-Q for the quarter ended June 30, 2014).*” SEC filing
“| License Agreement, dated January 7, 2024, by and between TG Therapeutics, Inc., TG Cell Therapy, Inc., and Precision BioSciences, Inc. (incorporated by reference to Exhibit 10.38 to the Registrant's Form 10-K for the year ended December 31, 2023).* |” SEC filing
Companies whose annual reports name TG THERAPEUTICS, INC. 2
“Revenue from Prevail Therapeutics, Inc. ("Prevail") and TG Therapeutics (as defined below) accounted for 77 % and 12 % of revenue during the year ended December 31, 2024, respectively.” SEC filing
“In addition, we may terminate the TG License Agreement if TG Therapeutics or any of its affiliates or sublicensees challenges the validity of any patents controlled by us.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.